je.st
news
Tag: bio
BIO Applauds Representatives for introducing bipartisan HR 3784.
2015-10-30 13:31:09| Industrial Newsroom - All News for Today
BIO applauded Representatives John Carney (D-DE), Sean Duffy (R-WI), Mike Quigley (D-IL), and Ander Crenshaw (R-FL) for introducing HR 3784, SEC Small Business Advocate Act. This legislation would establish Office of the Small Business Advocate at Securities and Exchange Commission (SEC) to facilitate small business capital formation and ensure SEC takes into account impacts of regulatory burdens on growing companies as it considers new compliance requirements.
Tags: bio
representatives
introducing
bipartisan
BIO Patient and Health Advocacy Summit draws 325 attendees.
2015-10-13 14:31:10| Industrial Newsroom - All News for Today
Bringing together patient advocacy groups, health care provider organizations, academia, government, and biotechnology industry representatives, BIO Patient and Health Advocacy Summit provides forum for lively discussion, networking, and educational programming to advance partnerships among stakeholders and to share best practices. During Summit, Clinical Trials Transformation Initiative launched their recommendations for Effective Engagement with Patient Groups Around Clinical Trials.
Tags: health
patient
bio
summit
BIO announces SPARK Showcase Event at BIO Investor Forum.
2015-10-12 14:31:10| Industrial Newsroom - All News for Today
Stanford University School of Medicine Spark Program and BIO announce the SPARK Showcase Event featuring the latest academic research for venture capital firms and business development executives seeking opportunities to expand their pipelines. Academics researchers will present their programs and engage in one-on-one discussions regarding potential collaborations. Each year, BIO Investor Forum hosts approximately 125 company presentations and sets up estimated 1,400 partnering meetings.
Tags: forum
event
bio
investor
BIO addresses data exclusivity provisions within TPP.
2015-10-09 14:31:11| Industrial Newsroom - All News for Today
In statement, BIO President and CEO Jim Greenwood said BIO is disappointed in reports from Atlanta that suggest Trade Ministers have failed to include 12 years of data exclusivity for biologics in Trans-Pacific Partnership agreement. BIO believes that 12 years of data exclusivity is a prerequisite to attract investment required to continue medical innovation and develop new biological cures and therapies. Failure of Asian-Pacific partners to agree to similar length of protection is short-sighted.
Tags: data
addresses
bio
provisions
BIO Issues Statement on PTO Patent Trial and Appeal Board ruling.
2015-10-05 14:31:10| Industrial Newsroom - All News for Today
Regarding recent ruling issued by PTO's Patent Trial and Appeal Board, BIO called the failure of PTO's Patent Trial and Appeal Board (PTAB) to properly assess important issues raised by said motion "disappointing." In addition to calling this ruling "cursory and erroneous," BIO said it "reinforces the immediate need for Congress and the PTO leadership to take clear and decisive action to prevent any further misuse and abuse of the Inter Partes Review process"
Tags: board
issues
statement
trial
Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] next »